Skip to content
Sign in
Venture capitalBacked 1 network startup

Sancus Capital

Spain-based investor with an empty profile; its only recorded network deal is Argentine clinical-data marketplace Cromodata's pre-seed.

Spain
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
1most often with PharmStars Ventures

How they invest

No description, thesis or sectors are recorded. The single network deal (Cromodata's $1.2M pre-seed, alongside PharmStars Ventures) suggests interest in health data and Spanish-speaking markets; anything more is unknown.

Stage and ticket

Unknown; participated in a $1.2M pre-seed (2025).

Geography

Unknown; Spain-based, observed deal in Argentina.

What makes them say yes

  • Health data/digital health (inferred)
  • Spanish-speaking founders or markets (inferred)
  • Unknown beyond this

Red flags

  • Thesis undocumented
  • Unknown

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Cromodata's founders are the warm path. Confirm Sancus's mandate and ticket before pitching anyone.

Portfolio

1 network startup · no other company

Single recorded deal; no pattern can be established.

Gaps in the portfolio

  • Thesis unknown

Network startups

  • CromodataSWC 2026 Finalist

    Argentine marketplace turning de-identified records from a 47–84-facility Latin American network into research- and AI-ready clinical datasets.

    Argentina · HealthTech

    • Pre-seed (first round) · $1.2M · 1 Sept 2025Source

Network startups that fit

3 analysed

Physician-founded Mallorca platform letting clinicians prescribe personalised lifestyle-medicine programmes, starting with menopause.

Mallorca clinical OS for lifestyle medicine with validated pilots: Spanish digital health, consistent with the one observed health deal.

30%confidence

Evidence from the records

  • “Mallorca-based startup building a "clinical operating system" for preventive medicine”
  • “Spain”
Intro path
Cromodata founders (Sancus portfolio).
First step
Ask Cromodata about Sancus's process, then pitch iKi.

CE-marked, ISO 13485 dermatology AI that supports diagnosis and scores severity from photos, partnering with NHS and Spanish health services.

Spanish CE-marked dermatology AI; health-data adjacent, but already seed-funded by Wayra, Mutua Ventures and Grupo Ribera.

25%confidence

Evidence from the records

  • “AI in dermatology (medical device)”
  • “Spain”
First step
Explore participation in Legit.Health's next round.

Mexican menopause FemTech pairing saliva hormone kits with AI symptom tracking, already retailing in Hong Kong through Mannings pharmacies.

Mexican menopause FemTech selling in Hong Kong: Spanish-speaking founder in digital health, very thin evidence of Sancus fit.

15%confidence

Evidence from the records

  • “FemTech – perimenopause / menopause”
  • “Mexico”
First step
Low priority until Sancus's focus is known.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with PharmStars Ventures

Sources

  1. 1trysignalbase.com/news/funding/cromodata-secures-12m-pre-seed-for-latam-healt

Profile compiled from public sources. Unknown fields are left empty rather than estimated.